Aces Diagnostics is focused on solving one of the biggest gaps in infectious disease diagnostics: the lack of accurate testing for Lyme disease.Continue reading
Category Archives: AZBio News
C-Path Appoints Biotech Executive and Investor Dr. Milad Alucozai to Board of Directors
TUCSON, Ariz., June 11, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Milad Alucozai, DrPH, MPH, M.Sc., to its Board of Directors.Continue reading
C-Path Appoints Biotechnology Leader and Veteran Life-Science Attorney Yalonda Howze to Board of Directors
TUCSON, Ariz., June 10, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Yalonda Howze, J.D., to its Board of Directors. Howze brings nearly two decades of executive leadership and legal experience across the biotechnology and life-science sectors, including her most recent current service as interim chief executive officer and president of Generation Bio.Continue reading
Critical Path Institute to Convene Drug Development Leaders at 2026 Global Impact Conference
Annual conference returns to Washington, D.C., Sept. 15-16; addresses challenges in establishing a new paradigm for how evidence of efficacy and safety is generated.Continue reading
AZBio Member Spotlight – Prickly Pear Health
Based in Arizona, Prickly Pear Health is building technology to uncover one of the most overlooked gaps in healthcare: the connection between women’s hormonal health and brain health.Continue reading
Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies
— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures —
— Advancing second-generation Emperor TAH development toward a fully implantable system —
Continue reading
AZBio Member Spotlight – Navi Nurses
Based in Arizona, Navi Nurses is redefining what personalized nursing care looks like outside of the hospital, ensuring that no patient or family has to navigate complex medical situations alone.Continue reading
NIH SBIR and STTR Parent Notices of Funding Opportunity (NOFOs) have officially been released
These programs provide non-dilutive funding to help small businesses advance innovative technologies and bring promising discoveries closer to commercialization. Whether you’re developing a new therapeutic, diagnostic, medical device, digital health solution, or research tool, NIH funding can help accelerate your path forward.Continue reading
Banner Health report shows Arizona research driving national medical innovation
Milestones in Research details 1,300 clinical and translational research studies, FDA-approved heart device, landmark Alzheimer’s prevention work
AZBio Member Spotlight – Gut-Brain Axis Therapeutics
Gut-Brain Axis Therapeutics is developing microbiota transplant therapy for treating gut-brain disorders in autism and related conditions. The company’s founding is deeply personal. Dr. James Adams, who leads the organization, has a daughter with autism, which motivated him 25 years ago to focus his research on treatments for the condition. 15 years ago, he led a study which demonstrated that gastrointestinal symptoms strongly correlated with autism symptoms, and that children with autism were missing beneficial bacteria and had harmful yeast. That led to their first clinical trial of microbiota transplant, which was very successful and led to 5 more, with the last 2 funded by Gut-Brain Axis Therapeutics.Continue reading